Ken Griffin’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Ken Griffin's ARQT Position: Q3 2026 in Review
Ken Griffin increased its Arcutis Biotherapeutics (ARQT) stake by 32% in Q3 2026, buying an estimated $9.7M and bringing the position to 1,531,642 shares worth $40.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1768.
Ken Griffin first reported a position in ARQT in Q1 2020 and has held it in 26 quarters since. 294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Ken Griffin held 1,531,642 shares of Arcutis Biotherapeutics worth $40.5M as of Q3 2026.
- Ken Griffin bought 371,628 Arcutis Biotherapeutics shares in Q3 2026, an estimated $9.7M.
- Arcutis Biotherapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1768 holding.
- Ken Griffin first reported a position in Arcutis Biotherapeutics in Q1 2020 and has held it in 26 quarters since.
- 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.